Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyper-Save: Sacubitril/Valsartan in Hypertension and Diabetic Nephropathy
NCT06501651Phase 4Not yet recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Aug 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sacubitril + valsartan in essential hypertension, diabetic nephropathy (DN), sponsored by Sichuan Provincial People's Hospital. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
essential hypertensiondiabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT06501651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06501651.